Work

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: current status and future perspective in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer.

Year: 2012
Type: article
Authors: Galvani E, Alfieri R, Giovannetti E, Cavazzoni A, Monica SL, Galetti M, Fumarola C, Bonelli M, Mor M, Tiseo M, Peters GJ, Petronini PG, ARDIZZONI, ANDREA
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W6981565862
FWCI:
Cites:
Cited by:
Related to: 10